Congo-Kinshasa: Strain-Specific Ebola Vaccines to Be Trialled in DR Congo, WHO Announces
- Words
- 33
- Chars
- 218
- AI summary
- Yes
Full story
The World Health Organization announced that trials for two vaccines against the Bundibugyo Ebola strain will begin. These trials are scheduled to start next week in the epicentre of the outbreak in the Democratic Republic of Congo.
[RFI] Two vaccines against the deadly Bundibugyo Ebola strain gripping the Democratic Republic of Congo are set to enter trials in the outbreak's epicentre next week, the World Health Organization announced on Tuesday.
Open article